Neuronal Nitric Oxide Synthase Inhibition Accelerated the Removal of Fluoxetine's Anxiogenic Activity in an Animal Model of Ptsd Publisher Pubmed



Sadeghi MA^{1, 2} ; Hemmati S^{3, 4} ; Yousefimanesh H^{3, 4} ; Fekrvand S^{3, 4} ; Foroutani L^{3, 4} ; Nassireslami E^{1, 2} ; Yousefi Zoshk M^{5, 6} ; Hosseini Y⁷ ; Dehpour AR^{3, 4} ; Chamanara M^{1, 2} Show Affiliations
Source: Behavioural Brain Research Published:2023

Abstract

While SSRIs are the current first-line pharmacotherapies against post-traumatic stress disorder (PTSD), they suffer from delayed onset of efficacy and low remission rates. One solution is to combine SSRIs with other treatments. Neuronal nitric oxide synthase (nNOS) has been shown to play a role in serotonergic signaling, and there is evidence of synergism between nNOS modulation and SSRIs in models of other psychiatric conditions. Therefore, in this study, we combined subchronic fluoxetine (Flx) with 7-nitroindazole (NI), a selective nNOS inhibitor, and evaluated their efficacy against anxiety-related behavior in an animal model of PTSD. We used the underwater trauma model to induce PTSD in rats. Animals underwent the open field (OFT) and elevated plus maze tests on days 14 (baseline) and 21 (post-treatment) after PTSD induction to assess anxiety-related behaviors. Between the two tests, the rats received daily intraperitoneal injections of 10 mg/kg Flx or saline, and were injected intraperitoneally before the second test with either 15 mg/kg NI or saline. The change in behaviors between the two tests was compared between treatment groups. Individual treatment with both Flx and NI had anxiogenic effects in the OFT. These effects were associated with modest increases in cFOS expression in the hippocampus. Combination therapy with Flx + NI did not show any anxiogenic effects, while causing even higher expression levels of cFOS. In conclusion, addition of NI treatment to subchronic Flx therapy accelerated the abrogation of Flx's anxiogenic properties. Furthermore, hippocampal activity, as evidenced by cFOS expression, was biphasically related to anxiety-related behavior. © 2022 Elsevier B.V.